SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-075322
Filing Date
2018-12-31
Accepted
2018-12-31 16:20:47
Documents
4
Period of Report
2018-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-42204_18k.htm 8-K 31681
2 EX-4.1 a18-42204_1ex4d1.htm EX-4.1 93018
3 EX-10.1 a18-42204_1ex10d1.htm EX-10.1 53937
4 GRAPHIC g422041lai001.jpg GRAPHIC 3927
  Complete submission text file 0001104659-18-075322.txt   185733
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 181260016
SIC: 2834 Pharmaceutical Preparations